PLX

Protalix BioTherapeutics (PLX)

About Protalix BioTherapeutics (PLX)

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Details

Daily high

$2.14

Daily low

$2.03

Price at open

$2.13

52 Week High

$3.19

52 Week Low

$1.32

Market cap

171.6M

Dividend yield

0.00%

Volume

8,365

Avg. volume

1.2M

P/E ratio

-25.21

Protalix BioTherapeutics News